SCOPUS 정보 검색 플랫폼

Therapeutic Drug Monitoring

Volumn 17, Issue 1, 1995, Pages 84-88

Measurement of the active leflunomide metabolite (A77 1726) by reverse-phase high-performance liquid chromatography

(4) Dias, Valeria C a Lucien, Jamie a LeGatt, Donald F a Yatscoff, Randall W a

a UNIVERSITY OF ALBERTA (Canada)

Author keywords

Drug stability; High performance liquid chromatography; Leflunomide; Metabolite A77 1726

Indexed keywords

DRUG METABOLITE; INTERLEUKIN 2; LEFLUNOMIDE; TERIFLUNOMIDE;

ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE ACTIVATION; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG POTENCY; DRUG SENSITIVITY; DRUG STABILITY; HUMAN; HUMAN EXPERIMENT; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RABBIT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ANILINE COMPOUNDS; ANIMAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMAN; HYDROXYBUTYRATES; ISOXAZOLES; RABBITS; SUPPORT, NON-U.S. GOV'T;

EID: 0028853980 PISSN: 01634356 EISSN: 15363694 Source Type: Journal
DOI: 10.1097/00007691-199502000-00014 Document Type: Article

Times cited : (29)

References (6)

1
- 0027529372
- Leflunomide, a novel immunomodulatory agent: In vitro analysis of the mechanism of immunosuppression
- Chong AS-F, Finnegau A, Jiang X, et al. Leflunomide, a novel immunomodulatory agent: in vitro analysis of the mechanism of immunosuppression. Transplant Proc1993; 25:747–749.
- (1993) Transplant Proc , vol.25 , pp. 747-749
- Chong, A.S.-F.¹ Finnegau, A.² Jiang, X.³

2
- 0027279125
- Leflunomide, a novel immunosuppressive agent
- Chong AS-F, Finnegan A, Jiang X, et al. Leflunomide, a novel immunosuppressive agent. Transplantation1993;55: 1361–1366.
- (1993) Transplantation , vol.55 , pp. 1361-1366
- Chong, A.-F.¹ Finnegan, A.² Jiang, X.³

3
- 0027469783
- Immunosuppressive effects of leflunomide in a cardiac allograft model
- Williams AJW, Xiao F, Foster PF, et al. Immunosuppressive effects of leflunomide in a cardiac allograft model. Transplant Proc1993;25:745–746.
- (1993) Transplant Proc , vol.25 , pp. 745-746
- Williams, A.¹ Xiao, F.² Foster, P.F.³

4
- 0026060988
- Prevention of kidney and skin graft rejection in rats by leflunomide, a new immunomodu-lating agent
- Küchle CCA, Thoenes GH, Langer KH, Schorlemmer HU, Bartlett RR, Schleyerbach R. Prevention of kidney and skin graft rejection in rats by leflunomide, a new immunomodu-lating agent. Transplant Proc1991;23:1083–1086.
- (1991) Transplant Proc , vol.23 , pp. 1083-1086
- Küchle, C.¹ Thoenes, G.H.² Langer, K.H.³ Schorlemmer, H.U.⁴ Bartlett, R.R.⁵ Schleyerbach, R.⁶

5
- 0027238470
- Effects of leflunomide on immune responses and models of inflammation
- Bartlett RR, Anagnostopulos H, Zielinski T, Mattar T, Schleyerbach R. Effects of leflunomide on immune responses and models of inflammation. Spring Semin Immu-nopathol1992;14:381–394.
- (1992) Spring Semin Immu-Nopathol , vol.14 , pp. 381-394
- Bartlett, R.R.¹ Anagnostopulos, H.² Zielinski, T.³ Mattar, T.⁴ Schleyerbach, R.⁵

6
- 0028279926
- Down-regulation of xenophile antibodies in an experimental animal model
- Ulrichs K, Wang H, Muller-Ruchholtz W. Down-regulation of xenophile antibodies in an experimental animal model. Transplant Proc1994;26:994–996.
- (1994) Transplant Proc , vol.26 , pp. 994-996
- Ulrichs, K.¹ Wang, H.² Muller-Ruchholtz, W.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.